Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.59T
24h Vol:
$3.71B
Dominance:
MSFT:5.14%
Stocklytics Platform
BETA
Instrument logo  MYO

Myomo Inc

MYO
81 / 100
High Growth
Penny Stock
$2.75arrow_drop_down-3.84%-$0.11

Performance History

Stocklytics logo
Key Stats
Open$2.89
Prev. Close$2.86
EPS-0.49
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap79430640.00
PE Ratio-
LOWHIGH
Day Range2.69
2.89
52 Week Range0.37
5.58
Ratios
P/B Ratio7.23
Revenue$18.52M
Operating M. %-39.85%
Earnings$0.00
Earnings Growth %26.73%
EBITDA Margin %-42.33%
ROE %-83.36%
EPS-0.49

Score Breakdown

81vs 53. Market Avg.

All Score 81 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

MYOMARKET
Value6639
Quality5640
Ownership2619
Growth8946
Dividends-37
check_circle

Myomo Inc's Price growth average in the last 3 years of 72.04% is great compared to market average of 6.84%. This indicates MYO could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$772.01
24H (%)arrow_drop_up0.32%
24H ($)$2.47
MARKET CAP$733.11B
PRICE$524.65
24H (%)arrow_drop_down-0.49%
24H ($)-$2.58
MARKET CAP$485.17B
PRICE$160.85
24H (%)arrow_drop_down-0.61%
24H ($)-$0.99
MARKET CAP$387.40B
PRICE$128.84
24H (%)arrow_drop_down-0.47%
24H ($)-$0.61
MARKET CAP$326.50B

About Myomo Inc (MYO)

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Paul R. Gudonis
Headquarters
Boston
Employees
100
Exchange
NYSE
add Myomo Inc to watchlist

Keep an eye on Myomo Inc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is Myomo Inc's (MYO) price per share?

The current price per share for Myomo Inc (MYO) is $2.8. The stock has seen a price change of -$0.01 recently, indicating a -0.35% change. This reflects the stock's recent market performance and investor sentiment.

question_mark
What is the 52-week high and low for Myomo Inc (MYO)?

For Myomo Inc (MYO), the 52-week high is $5.58, which is 95.79% from the current price. The 52-week low is $0.37, the current price is 668.19% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

question_mark
Is Myomo Inc (MYO) a growth stock?

Myomo Inc (MYO) has shown an average price growth of 72.04% over the past three years. It has received a score of 95 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Myomo Inc as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

question_mark
What is Myomo Inc (MYO) stock price performance year to date (YTD)?

As of the latest data, Myomo Inc (MYO) has a year-to-date price change of -40.16%. Over the past month, the stock has experienced a price change of -12.58%. Over the last three months, the change has been -14.16%. Over the past six months, the figure is 256.25%. Looking at a longer horizon, the five-year price change stands at -91.88%.

question_mark
Is Myomo Inc (MYO) a profitable company?

Myomo Inc (MYO) has a net income of -$7.85M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.58% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -39.85% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $18.53M, with a revenue growth rate of 19.1%, providing insight into the company's sales performance and growth. The gross profit is $12.71M. Operating income is noted at -$8.03M. Furthermore, the EBITDA is -$7.84M.

question_mark
What is the market capitalization of Myomo Inc (MYO)?

Myomo Inc (MYO) has a market capitalization of $79.43M. The average daily trading volume is 262.07K, indicating the stock's liquidity and investor engagement.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.